Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 3

Epikardiyal yağ dokusu: Fizyoloji, patofizyoloji ve klinik uygulamalar hakkında bir derleme

Epicardial adipose tissue: A review of physiology, pathophysiology, and clinical applications

Pages
261–265
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We also have tried to discuss its relationship to metabolic syndrome and coronary atherosclerosis in the lights of recent findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Visceral fat tissue is an important predictor of cardio-metabolic diseases, carrying more risk than general fat accumulation.
📊
Key Findings & Data:Epicardial fat, a particular form of visceral fat deposited around the heart, is considered an important cardiovascular risk predictor, in view of producing and releasing several adipo-cytokines.
💡
Conclusion & Impact:We also have tried to discuss its relationship to metabolic syndrome and coronary atherosclerosis in the lights of recent findings.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Visceral fat tissue is an important predictor of cardio-metabolic diseases, carrying more risk than general fat accumulation. Epicardial fat, a particular form of visceral fat deposited around the heart, is considered an important cardiovascular risk predictor, in view of producing and releasing several adipo-cytokines. There is growing evidence about the physiological and metabolic importance of epicardial fat. Epicardial fat thickness and volume have both strong correlation between obesity, impaired fasting glucose, insulin resistance, metabolic syndrome, hyper- tension, diabetes mellitus, and atherosclerosis. Epicardial fat can be assessed by transthoracic echocardiography, cardiac magnetic resonance imaging, and computed tomography. In this article, we reviewed the anatomy, physiology, function, and the methods of assessment of epicar- dial fat tissue. We also have tried to discuss its relationship to metabolic syndrome and coronary atherosclerosis in the lights of recent findings.

Özet

Kardiyo-metabolik hastalıkların önemli bir belirteci olan visseral yağ dokusu genel yağ birikiminden daha fazla risk oluşturmaktadır. Visseral yağın kalp etrafında depolanan özel bir şekli olan epikardiyal yağ, çok sayıda adipo-sitokin üretme ve salma yeteneği sayesinde önemli bir kardiyovasküler risk belirteci olarak düşünülmektedir. Epikardiyal yağın fizyolojik ve metabolik önemine dair artan deliller mevcuttur. Epikardiyal yağ kalınlığı ve hacminin her ikisinin de obezite, bozulmuş glikoz intoleransı, metabolik sendrom, hipertansiyon, diyabet ve ateroskleroz ile güçlü korelasyonları mevcuttur. Epikardiyal yağ transtorasik ekokardiyografi, kardiyak manyetik rezonans ve bilgisaarlı tomografi ile değerlendirilebilir. Bu yazıda epikardiyal yağ dokusunun anatomisini, fizyolojisini, fonksiyonunu ve değerlendirme metotlarını gözden geçirdik. Aynı zamanda metabolik sendrom ve koroner ateroskleroz ile ilişkisini son bilgiler ışığında tartışmaya çalıştık.

🔖

Cite This Article

ÖZVEREN, O., ŞENGÜL, C. (2022). Epikardiyal yağ dokusu: Fizyoloji, patofizyoloji ve klinik uygulamalar hakkında bir derleme. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 3, 261–265. https://ajindex.com/articles/436193

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Roy PE. Lipid droplets in the heart interstitium: concentration and distribution. Recent Adv Stud Cardiac Struct Metab 1975; 10: 17-27
  2. Wheeler GL, Shi R, Beck SR, Langefeld CD, Lenchik L, Wagenknecht LE, et al. Pericardial and visceral adipose tissue measured volumetrically with computed tomography are highly associated in type 2 diabetic families. Invest Radiol 2005; 40: 97-101. [CrossRef] 3. Bambace C, Telesca M, Zoico E, Sepe A, Olioso D, Rossi A, et al. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011; 20: 153-6. [CrossRef] 4. Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 2011; 22: 450-7. [CrossRef] 5. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-6. [CrossRef] 6. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, et al. Enhanced coronary vasa vasorum neovascularisation in experimental hypercholesterolemia. J Clin Invest 1998; 101: 1551-6. [CrossRef] 7. Yudkin JS, Eringa E, Stehouwer CD. Vasocrine signaling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-20. [CrossRef] 8. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, fetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225-32. [CrossRef] 9. Sacks HS, Fain JN, Holman B, Cheema P Chary A, Parks F, et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 2009; 94: 3611-5. [CrossRef] 10. Keegan J, Gatehouse PD, Yang GZ, Firmin DN. Spiral phase velocity mapping of left and right coronary artery blood flow: correlation for through-plane motion using selective fat-only excitation. J Magn Reson Imaging 2004; 20: 953-60. [CrossRef] 11. Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, et al. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res 2009; 41: 227-31. [CrossRef] 12. Fox CS, Gona P Hoffmann U, Porter SA, Salton CJ, Massaro JM, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and fun